Yan Wang

19.0k total citations · 6 hit papers
672 papers, 12.2k citations indexed

About

Yan Wang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yan Wang has authored 672 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 235 papers in Pulmonary and Respiratory Medicine, 211 papers in Oncology and 166 papers in Molecular Biology. Recurrent topics in Yan Wang's work include Lung Cancer Treatments and Mutations (150 papers), Lung Cancer Research Studies (82 papers) and Cancer Immunotherapy and Biomarkers (50 papers). Yan Wang is often cited by papers focused on Lung Cancer Treatments and Mutations (150 papers), Lung Cancer Research Studies (82 papers) and Cancer Immunotherapy and Biomarkers (50 papers). Yan Wang collaborates with scholars based in China, United States and Canada. Yan Wang's co-authors include Peifu Tang, Jing Shen, Fangke Hu, Cheng‐Ying Jiang, Junling Li, Yuchun Zhu, Yongqiang Wang, Haiyan Xu, Diane J. Burgess and Shuoxin Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Yan Wang

611 papers receiving 12.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preoperative predictors for mortality following hip fracture surgery: A systematic review and meta-analysis

2011 504 citations Yan Wang et al. profile →
Molecular mechanisms of ATP secretion during immunogenic cell death

2013 437 citations Yan Wang et al. profile →
Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients

2018 390 citations Zhe Yang, Nong Yang et al. Clinical Cancer Research profile →
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota

2019 349 citations Yan Wang et al. profile →
What could promote farmers to replace chemical fertilizers with organic fertilizers?

2018 327 citations Yan Wang et al. profile →
Structures, properties and application of alginic acid: A review

2020 286 citations Yan Wang et al. profile →

Peers

Countries citing papers authored by Yan Wang

Since Specialization

Citations

This map shows the geographic impact of Yan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Wang more than expected).

Fields of papers citing papers by Yan Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Wang. The network helps show where Yan Wang may publish in the future.

Co-authorship network of co-authors of Yan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Wang. A scholar is included among the top collaborators of Yan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Wang. Yan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of biomarkers for tumor regression grade in esophageal squamous cell carcinoma patients after neoadjuvant chemoradiotherapy 2025 ·Frontiers in Oncology ·(unknown), Yan Wang, Jun Chen, Zi‐jun Xu, Ting‐juan Zhang, Lu Sun, Li Zhu, (unknown), Chaoyang Wu, (unknown), Dianjun Wang, (unknown)	1
2	The association between digital addiction and interpersonal relationships: A systematic review and meta-analysis 2024 ·Clinical Psychology Review ·(unknown), Tingting Liao, Yan Wang, (unknown), Jianguang Zeng	6
3	An LCC-CS bilateral matching network for high efficiency energy conversion in high-frequency piezoelectric rotary ultrasonic machining system 2024 ·Measurement ·(unknown), Guofu Gao, Yi Wang, Yan Wang, (unknown), (unknown), (unknown), Daohui Xiang	2
4	Overexpression of ELF1 combined with MMP9 is associated with prognosis and tumor microenvironment in gastric cancer 2024 ·Experimental and Therapeutic Medicine ·(unknown), Xiaoyan Ren, (unknown), Yan Wang	0
5	Development of patient‐specific pre‐treatment verification procedure for FLASH proton therapy based on time resolved film dosimetry 2024 ·Medical Physics ·(unknown), Jérémy Godart, (unknown), Yan Wang, (unknown), Steven Habraken, Mischa S. Hoogeman	2
6	ATP6AP1 as a potential prognostic biomarker in CRC by comprehensive analysis and verification 2024 ·Scientific Reports ·Shijie Zhang, Yan Wang, Xiaodong Zhang, (unknown), Hao Wu, (unknown), Wentao Fan, Li Liu, (unknown), Wenqing Gao	2
7	Blood flow restriction combined with resistance training on muscle strength and thickness improvement in young adults: a systematic review, meta-analysis, and meta-regression 2024 ·Frontiers in Physiology ·(unknown), Jianghua He, Yan Wang	2
8	Global, regional and national burden due to retinoblastoma in children aged younger than 10 years from 1990 to 2021 2024 ·BMC Medicine ·(unknown), Lijun Zhang, Jie Zhang, Jinghua Jiao, (unknown), Yan Wang, (unknown), Ching‐Yu Cheng, Honghua Yu, (unknown), Lei Liu	3
9	Preparation of porous NiO/In2O3 nanoflower-like composites and their dual selectivity for CO/CH4 2023 ·Materials Research Bulletin ·Saisai Zhang, Jintao Li, (unknown), Bowen Zhang, Yan Wang, Zhanying Zhang	16
10	TORCH-R trial protocol: hypofractionated radiotherapy combined with chemotherapy and toripalimab for locally recurrent rectal cancer: a prospective, single-arm, two-cohort, phase II trial 2023 ·Frontiers in Oncology ·Juefeng Wan, Ruiyan Wu, (unknown), Lijun Shen, Hui Zhang, Yan Wang, Yaqi Wang, Shujuan Zhou, Yajie Chen, Fan Xia, Zhen Zhang	2
11	Multi-level progressive transfer learning for cervical cancer dose prediction 2023 ·Pattern Recognition ·Lu Wen, Jianghong Xiao, Jie Zeng, Chen Zu, Xi Wu, Jiliu Zhou, Xingchen Peng, Yan Wang	23
12	Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center study 2023 ·Frontiers in Oncology ·Kailun Fei, Gang Guo, Jie Wang, Zhijie Wang, Yan Wang, Xuezhi Hao, Jia Zhong, (unknown), Wei Guo, (unknown), (unknown), Jie Xu, Fengwei Tan, Xiaofei Zhuang, Jianchun Duan	4
13	Biofuneling lignin-derived compounds into lipids using a newly isolated Citricoccus sp. P2 2023 ·Bioresource Technology ·Yan Wang, Chaobing Luo, Yuanqiu Li	8
14	Up-regulated SPP1 increases the risk from IPF to lung cancer via activating the pro-tumor macrophages 2023 ·Computational and Structural Biotechnology Journal ·Tingting Chen, (unknown), (unknown), Yuquan Wang, Yan Wang, (unknown), Mingyue Liu, (unknown), (unknown), Zhangxiang Zhao, Haihai Liang, Yunyan Gu	8
15	EP12.01-57 Unresectable Advanced NSCLC Transformed to Resectable NSCLC through Effective Aumolertinib Neoadjuvant Therapy: A Case Report 2023 ·Journal of Thoracic Oncology ·Chen Chen, Yan Wang, (unknown), Yongxi Song, Ya‐ling Tang, (unknown), Qing Li, Xiaolei Zhang, Xiaochen Yang, Liang Guo	0
16	1883MO MEDI5752 (volrustomig), a novel PD-1/CTLA-4 bispecific antibody, in the first-line (1L) treatment of 65 patients (pts) with advanced clear cell renal cell carcinoma (aRCC) 2023 ·Annals of Oncology ·Martin H. Voss, Benjamin Garmezy, (unknown), J.P. Maroto Rey, André Mansinho, Alejo Rodríguez‐Vida, Júlio Oliveira, Martien van Dongen, (unknown), Sylvie Négrier, Ben Tran, Benedito A. Carneiro, (unknown), Sun Young Rha, Yan Wang, Shelby D. Gainer, Zhiyuan Tang, Ikbel Achour, (unknown), Laurence Albigès	7
17	Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer 2022 ·BMC Medicine ·Chengming Liu, Lu Yang, Haiyan Xu, Sufei Zheng, Zhanyu Wang, Sihui Wang, Yaning Yang, (unknown), Xiaoli Feng, Nan Sun, Yan Wang, Jie He	55
18	KRAS ‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer 2022 ·Cancer Communications ·Chengming Liu, Sufei Zheng, Zhanyu Wang, Sihui Wang, Xin‐Feng Wang, Lu Yang, Haiyan Xu, Zheng Cao, Xiaoli Feng, Qi Xue, Yan Wang, Nan Sun, Jie He	99
19	Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients breakdown → 2018 ·Clinical Cancer Research ·Zhe Yang, Nong Yang, Qiuxiang Ou, Yi Xiang, Tao Jiang, Xue Wu, Hua Bao, Xiaoling Tong, Xiaonan Wang, Yang Shao, Yunpeng Liu, Yan Wang, Caicun Zhou	390
20	A Small-Molecule Modulator of the Tumor-Suppressor miR34a Inhibits the Growth of Hepatocellular Carcinoma 2014 ·Cancer Research ·Zhangang Xiao, Chi Han Li, Stephen L. Chan, Feiyue Xu, Feng Lu, Yan Wang, (unknown), Joseph J.�Y. Sung, Christopher H.K. Cheng, Yangchao Chen	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact